REFERENCES
- Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med. 1999; 341: 1284–1291, [PUBMED], [INFOTRIEVE], [CSA]
- Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol. 2003; 42: 346–351, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulku B Y, Muftuoglu A U. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis. 1984; 43: 783–789, [PUBMED], [INFOTRIEVE]
- Evereklioglu C, Turkoz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm. 2002; 11: 87–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Itoh R, Takenaka T, Okitsu-Negishi S, Matsushima K, Mizoguchi M. Interleukin 8 in Behcet's disease. J Dermatol. 1994; 21: 397–404, [PUBMED], [INFOTRIEVE]
- Alpsoy E, Kodelja V, Goerdt S, Orfanos C E, Zouboulis C HC. Serum of patients with Behcet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 2003; 206: 225–232, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jones S A, Dewald B, Clark-Lewis I, Baggiolini M. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2. J Biol Chem. 1997; 272: 16166–16169, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Premack B A, Schall T J. Chemokine receptors: Gateways to inflammation and infection. Nat Med. 1996; 2: 1174–1178, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rollins B J. Chemokines. Blood. 1997; 90: 909–928, [PUBMED], [INFOTRIEVE], [CSA]
- Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000; 18: 217–242, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mellado M, Rodriguez-Frade J M, Manes S, Martinez A C. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu Rev Immunol. 2001; 19: 397–421, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol. 1994; 55: 97–179, [PUBMED], [INFOTRIEVE], [CSA]
- Proost P, Wolf-Peeters C, De, Conings R, Opdenakker G, Billiau A, Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993; 150: 1000–1010, [PUBMED], [INFOTRIEVE]
- Lee J, Horuk R, Rice G C, Bennett G L, Camerato T, Wood W I. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem. 1992; 267: 16283–16287, [PUBMED], [INFOTRIEVE]
- Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. High- and low-affinity binding of Gro alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A. 1992; 89: 10542–10546, [PUBMED], [INFOTRIEVE], [CSA]
- Evereklioglu C, Turkoz Y, Inaloz H S, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker. J Am Acad Dermatol. 2002; 46: 50–54, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- L'Heureux G P, Bourgoin S, Jean N, McColl S R, Naccache P H. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: Interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood. 1995; 85: 522–531, [PUBMED], [INFOTRIEVE], [CSA]
- Jones S A, Wolf M, Qin S, Mackay C R, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci U S A. 1996; 93: 6682–6686, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol. 2001; 126: 551–559, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990; 335: 1078–1080
- Wang L M, Kitteringham N, Mineshita S, Wang J Z, Nomura Y, Koike Y, Miyashita E. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behcet's disease. Arch Dermatol Res. 1997; 289: 444–447, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zouboulis C C, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos C E. Adamantiades-Behcet's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res. 2000; 292: 279–284, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaburaki T, Fujino Y, Kawashima H, Merino G, Numaga J, Chen J, Matsushima K. Plasma and whole-blood chemokine levels in patients with Behcet's disease. Graefes Arch Clin Exp Ophthalmol. 2003; 241: 353–358, [PUBMED], [INFOTRIEVE], [CSA]
- Harter L, Petersen F, Flad H D, Brandt E. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: Requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol. 1994; 153: 5698–5708, [PUBMED], [INFOTRIEVE]
- Cochran B H, Reffel A C, Stiles C D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 1983; 33: 939–947, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Oquendo P, Alberta J, Wen D Z, Graycar J L, Derynck R, Stiles C D. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem. 1989; 264: 4133–4137, [PUBMED], [INFOTRIEVE]
- Schroder J M, Persoon N L, Christophers E. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide/interleukin 8, a second neutrophil-activating protein: NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med. 1990; 171: 1091–1100, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Haskill S, Peace A, Morris J, Sporn S A, Anisowicz A, Lee S W, Smith T, Martin G, Ralph P, Sager R. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A. 1990; 87: 7732–7736, [PUBMED], [INFOTRIEVE], [CSA]
- Walz A, Burgener R, Car B, Baggiolini M, Kunkel S L, Strieter R M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med. 1991; 174: 1355–1362, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Asagoe K, Yamamoto K, Takahashi A, Suzuki K, Maeda A, Nohgawa M, Harakawa N, Takano K, Mukaida N, Matsushima K, Okuma M, Sasada M. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol. 1998; 160: 4518–4525, [PUBMED], [INFOTRIEVE]
- Evereklioglu C, Er H, Turkoz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm. 2002; 11: 87–93, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986; 104: 847–851, [PUBMED], [INFOTRIEVE]